OnKure Therapeutics, Inc. (OKUR) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$51.83M | -1.4% |
| 2024 | -$51.12M | -48.0% |
| 2023 | -$34.55M | +27.1% |
| 2022 | -$47.36M | -24.7% |
| 2021 | -$37.98M | -104.9% |
| 2020 | -$18.54M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$51.83M | -1.4% |
| 2024 | -$51.12M | -48.0% |
| 2023 | -$34.55M | +27.1% |
| 2022 | -$47.36M | -24.7% |
| 2021 | -$37.98M | -104.9% |
| 2020 | -$18.54M | — |